The Global Glyphosate Study will provide results that will be informative for both hazard and risk assessment. Hazard assessment determines if a substance capable or not of inducing a certain effect (neurotoxicity, endocrine disruptor, cancer). Risk assessment quantifies at what dose a certain effect might occur. The Global Glyphosate Study investigates dose ranges that encompasses both doses that are considered safe in humans, namely the EU acceptable daily intake (ADI), and doses that are considered without adverse effects in animals, the EU no-observed-adverse-effect level (NOAEL) for glyphosate. Therefore, the results provided by the Global Glyphosate Study are particularly relevant for risk assessment, being for these doses currently considered as “safe”.
